Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$66.25 +0.79 (+1.21%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Assets (2010 - 2026)

Updated

Arrowhead Pharmaceuticals (ARWR) posted Assets of $2.11 billion for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 53.0% from $1.38 billion a year earlier but down 6.9% from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Assets (2010 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Assets came in at $1.39 billion, up 21.5% from FY2024.

  • Annual Assets has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 21.5% (FY2020 to FY2025).
  • In prior fiscal years, Arrowhead Pharmaceuticals' Assets was $1.14 billion in FY2024 (+48.9%), $765.55 million in FY2023 (+10.6%), $691.94 million in FY2022 (-2.6%) and $710.15 million in FY2021 (+35.9%).
  • Quarterly Assets has run from a low of $626.29 million in fiscal Q1 2024 to a high of $2.27 billion in fiscal Q2 2026 over five years.
  • On a year-over-year basis, Assets has increased in each of the last ten quarters, with growth averaging 51.1% over the last eight quarters.
  • The strongest year-over-year quarter for Assets in the past five years was fiscal Q2 2025, with growth of 64.7%; the weakest was fiscal Q1 2024, with a decline of 29.7%.
  • According to Business Quant data, Assets for the three prior fiscal quarters was $2.27 billion (Q2 2026), $1.6 billion (Q1 2026) and $1.39 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Arrowhead Pharmaceuticals 9.24 Bn 4.02 Bn - 2.11 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.11 Bn
Mar 31, 2026 2.27 Bn
Dec 31, 2025 1.60 Bn
Sep 30, 2025 1.39 Bn
Jun 30, 2025 1.38 Bn
Mar 31, 2025 1.57 Bn
Dec 31, 2024 1.01 Bn
Sep 30, 2024 1.14 Bn
Jun 30, 2024 883.76 Mn
Mar 31, 2024 955.15 Mn
Dec 31, 2023 626.29 Mn
Sep 30, 2023 765.55 Mn
Jun 30, 2023 795.86 Mn
Mar 31, 2023 891.31 Mn
Dec 31, 2022 891.49 Mn
Sep 30, 2022 691.94 Mn
Jun 30, 2022 751.78 Mn
Mar 31, 2022 703.58 Mn
Dec 31, 2021 638.54 Mn
Sep 30, 2021 710.15 Mn
API Access

Arrowhead Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=ARWR&period=max&api_key=YOUR_API_KEY